Symbiotec Pharmalab LimitedSYMBIOTECNSE
Monitoring Agency Report issued by the CARE Edge Ratings, Monitoring Agency, appointed by the Company for the…
As filed · The Monitoring Agency Report issued by the CARE Edge Ratings, Monitoring Agency, appointed by the Company for the utilisation and application of funds raised through the Initial Public Offer (IPO) of
Special SituationMajormateriality 75 out of 100
What happened
FactThe Monitoring Agency Report issued by the CARE Edge Ratings, Monitoring Agency, appointed by the Company for the utilisation and application of funds raised through the Initial Public Offer (IPO) of the Company for the quarter year ended September 30, 2026. (Formerly known as Symbiotec Pharmalab Pvt. Ltd.). utilisation and application of funds raised through the Initial Public Offer (IPO) of the Company.